GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ovctek China Inc (SZSE:300595) » Definitions » Capital Expenditure

Ovctek China (SZSE:300595) Capital Expenditure : ¥-226.97 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ovctek China Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Ovctek China's cash flow for capital expenditures for the three months ended in Mar. 2024 was ¥-64 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-226.97 Mil.

Ovctek China Capital Expenditure Historical Data

The historical data trend for Ovctek China's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovctek China Capital Expenditure Chart

Ovctek China Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.11 -94.42 -137.81 -129.39 -197.93

Ovctek China Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.17 -51.28 -64.71 -46.78 -64.21

Ovctek China Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-226.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ovctek China (SZSE:300595) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ovctek China Inc (SZSE:300595) » Definitions » Capital Expenditure
Comparable Companies
SHSE:688301 SZSE:300888 SZSE:300573 SHSE:688050 SHSE:603087 SZSE:002432 SHSE:688029 SZSE:300677 SZSE:300171 SHSE:688575 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 4899 Wangjiang West Road, High-tech Zone, Anhui Province, Hefei, CHN, 230088
Website
http://www.orthok.cn
Ovctek China Inc is a China-based company engaged in the research and development, production, and sales of rigid gas permeable contact lens products. Its products include Hard Mirror, Mirror Teshu family, High-end ophthalmic products, and Security products. The company-owned trademarks are DreamVision, DreamDawei, Ri Dawei, Hua Cone, Jing Teshu, openvision, and Mengshiqing among others.
Executives
Tao Yue Qun Directors, executives
Directors, executives
Yin Yin Director

Ovctek China (SZSE:300595) Headlines

No Headlines